Red Flags Detected

  • Auditor Change (new) — The company dismissed KPMG and replaced them with Ernst & Young, though the filing indicates no disagreements or reportable events occurred.
NASDAQ: STOK Stoke Therapeutics, Inc. 8-K

Stoke Therapeutics replaces auditor KPMG with Ernst & Young effective March 23, 2026

Filed March 27, 2026 · Period ending March 23, 2026 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade STOK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · Jun 5, 2026 5:19 PM